A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to
Severely Active Crohn's Disease
Does guselkumab help patients with Crohn's disease?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
The purpose of this program is to evaluate the efficacy and safety of guselkumab (an
injection under the skin) in participants with Crohn's disease.
Inclusion Criteria: Have Crohn's disease or fistulizing Crohn's disease for at least
3 months duration (a minimum of 12 weeks). Have demonstrated intolerance or inadequate
response to conventional or biologic therapy for Chrohn's disease.
Lead Researcher (Principal Investigator)
Lead Researcher: Lawrence Saubermann
Study Contact InformationStudy Coordinator: Study Contact
Phone: (844) 434-4210
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search